• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    4/25/24 1:57:17 PM ET
    $ACON
    $AIRE
    $ATNI
    $AZN
    Medical Specialities
    Health Care
    Real Estate
    Finance
    Get the next $ACON alert in real time by email

    Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.

    Caterpillar reported a first-quarter fiscal 2024 revenue of $15.8 billion, a slight decrease of 0.4% year-over-year, missing the consensus of $16.216 billion. CAT's adjusted earnings of $5.60 per share, compared to $4.91 a year ago, topped the consensus of $5.14, according to data from Benzinga Pro.

    Caterpillar shares dipped 6.6% to $339.37 on Thursday.

    Here are some other stocks moving in today’s mid-day session.

    Gainers

    • Barfresh Food Group, Inc. (NASDAQ:BRFH) surged 87.2% to $2.05.
    • Safe & Green Holdings Corp. (NASDAQ:SGBX) shares jumped 80% to $0.26. Safe & Green Holdings said it has entered into an agreement to produce 4 modular electrical distribution centers as part of a multi-unit order for a client serving the big box retailer market.
    • Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) shares gained 37.2% to $2.2250 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced an $8 price target.
    • Aclarion, Inc. (NASDAQ:ACON) rose 35% to $0.3899.
    • reAlpha Tech Corp. (NASDAQ:AIRE) gained 28.5% to $1.4906 after jumping 93% on Wednesday.
    • OptiNose, Inc. (NASDAQ:OPTN) rose 27.5% to $1.1806 after the company issued corporate updates, expecting to produce positive income from operations for the full year 2025.
    • Intelligent Living Application Group Inc. (NASDAQ:ILAG) shares climbed 21.3% to $0.6550 after gaining over 12% on Wednesday.
    • P.A.M. Transportation Services, Inc. (NASDAQ:PTSI) surged 19.8% to $17.42 after the company announced a self-tender offer to purchase up to 550,000 shares at a price not less than $15.50-$18.00 per share.
    • SuperCom Ltd. (NASDAQ:SPCB) climbed 19% to $0.2663. SuperCom received over $5 million in new orders from European Governments.
    • Ultralife Corporation (NASDAQ:ULBI) climbed 16.6% to $10.19 after the company reported better-than-expected quarterly financial results.
    • Impinj, Inc. (NASDAQ:PI) gained 16% to $140.21 after reporting better-than-expected first-quarter financial results.
    • Cidara Therapeutics, Inc. (NASDAQ:CDTX) gained 13.9% to $14.00 after the company announced the divestiture of rezafungin to Mundipharma, reacquired global development and commercial rights to CD388 and announced $240 million in private placement financing.
    • Sleep Number Corporation (NASDAQ:SNBR) surged 11.5% to $15.13 following first-quarter results.
    • Predictive Oncology Inc. (NASDAQ:POAI) rose 10.7% to $1.49. Fujifilm and Predictive Oncology announced collaboration to reduce protein interference in bacterial endotoxin detection testing of biopharmaceuticals.
    • Strategic Education, Inc. (NASDAQ:STRA) jumped 10% to $110.78 following upbeat results.
    • Tyler Technologies, Inc. (NYSE:TYL) gained 9.6% to $459.39 after the company reported better-than-expected first-quarter EPS and sales. Additionally, the company provided upbeat guidance for FY24.
    • TransUnion (NYSE:TRU) climbed 8.9% to $74.83 after the company reported better-than-expected first-quarter financial results. The company also provided upbeat guidance for second quarter
    • AstraZeneca PLC (NYSE:AZN) rose 5.8% to $75.35 following a first-quarter revenue beat.
    • Teradyne, Inc. (NYSE:TER) gained 5% to $105.71 after the company posted upbeat first-quarter results and issued strong second-quarter forecast.

    Losers

    • E-Home Household Service Holdings Limited (NASDAQ:EJH) shares dipped 75% to $0.7192.
    • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) fell 39.3% to $0.2581. Chicken Soup For The Soul Entertainment received delinquency letter from the Nasdaq.
    • Hanryu Holdings, Inc. (NASDAQ:HRYU) shares dropped 37% to $0.3330. Hanryu Holdings received delinquency notice from the Nasdaq for late annual report filing.
    • ATN International, Inc. (NASDAQ:ATNI) fell 29% to $20.39 as the company posted weak quarterly sales and slashed FY24 revenue forecast.
    • Brand Engagement Network, Inc. (NASDAQ:BNAI) fell 27.3% to $2.71.
    • Huize Holding Limited (NASDAQ:HUIZ) shares dipped 26% to $0.39.
    • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) fell 24% to $1.7283.
    • Hertz Global Holdings, Inc. (NASDAQ:HTZ) dipped 23% to $4.4299 after the company mixed first-quarter financial results.
    • Organogenesis Holdings Inc. (NASDAQ:ORGO) fell 17.8% to $2.44
    • Orion Group Holdings, Inc. (NYSE:ORN) fell 17% to $6.60 following weak quarterly sales.
    • JAKKS Pacific, Inc. (NASDAQ:JAKK) fell 16.4% to $19.58 following a wider-than-expected quarterly loss.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) fell 16.4% to $3.3001 after dipping 15% on Wednesday.
    • Brookline Bancorp, Inc. (NASDAQ:BRKL) dipped 13.8% to $8.23 following downbeat quarterly results.
    • Ethan Allen Interiors Inc. (NYSE:ETD) fell 13.5% to $28.91 following downbeat quarterly results.
    • MarineMax, Inc. (NYSE:HZO) shares fell 13.5% to $23.50 after the company posted downbeat quarterly results and slashed FY24 EPS guidance.
    • ESGL Holdings Limited (NASDAQ:ESGL) shares fell 12.9% to $0.5499.
    • Harley-Davidson, Inc. (NYSE:HOG) declined 12.7% to $34.45 following first-quarter results.
    • Meta Platforms, Inc. (NASDAQ:META) shares declined 11.3% to $437.50 after reporting first-quarter results.
    • Biophytis S.A. (NASDAQ:BPTS) fell 9.7% to $8.57. Biophytis announced transfer of ADSs to OTC Market.
    • International Business Machines Corporation (NYSE:IBM) fell 8.6% to $168.24 after the company reported mixed first-quarter financial results. The company also announced it will acquire HashiCorp.
    • Textron Inc. (NYSE:TXT) shares fell 12% to $82.78 following weaker-than-expected quarterly earnings.
    • FirstCash Holdings, Inc. (NASDAQ:FCFS) dipped 10.6% to $118.00 following weak quarterly sales.
    • Whirlpool Corporation (NYSE:WHR) fell 9.2% to $95.98 following first-quarter results.
    • BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) dipped 9% to $83.05 after the company reported first-quarter financial results.
    • Reliance, Inc. (NYSE:RS) fell 8.8% to $285.73 after the company reported worse-than-expected first-quarter financial results.
    • AZZ Inc. (NYSE:AZZ) dipped 8.6% to $75.28. AZZ announced a proposed public offering of 4 million shares of common stock.
    • Southwest Airlines Co. (NYSE:LUV) shares declined 7.7% to $27.03 after the company reported worse-than-expected first-quarter financial results.
    • Bristol-Myers Squibb Company (NYSE:BMY) fell 6.8% to $45.50 following first-quarter earnings.
    • ServiceNow, Inc. (NYSE:NOW) shares fell 5.6% to $704.40 after the company reported first-quarter financial results.
    • Graco Inc. (NYSE:GGG) shares slipped 5.2% to $84.67 following downbeat first-quarter results.

    Now Read This: Top 3 Financial Stocks That Could Sink Your Portfolio This Quarter

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $AIRE
    $ATNI
    $AZN

    CompanyDatePrice TargetRatingAnalyst
    Harley-Davidson Inc.
    $HOG
    3/11/2026$15.00Underweight
    Wells Fargo
    Meta Platforms Inc.
    $META
    3/5/2026Buy → Neutral
    Arete
    Meta Platforms Inc.
    $META
    3/5/2026Hold → Buy
    Erste Group
    AZZ Inc.
    $AZZ
    3/2/2026$132.00Overweight → Equal Weight
    Wells Fargo
    Southwest Airlines Company
    $LUV
    2/27/2026$66.00Hold → Buy
    TD Cowen
    Bristol-Myers Squibb Company
    $BMY
    2/25/2026$60.00Sector Perform
    RBC Capital Mkts
    International Business Machines Corporation
    $IBM
    2/25/2026$236.00Sell → Neutral
    UBS
    Meta Platforms Inc.
    $META
    2/23/2026$849.00 → $856.00Overweight
    Wells Fargo
    More analyst ratings

    $ACON
    $AIRE
    $ATNI
    $AZN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on Harley-Davidson with a new price target

    Wells Fargo initiated coverage of Harley-Davidson with a rating of Underweight and set a new price target of $15.00

    3/11/26 8:37:56 AM ET
    $HOG
    Motor Vehicles
    Consumer Discretionary

    Meta Platforms downgraded by Arete

    Arete downgraded Meta Platforms from Buy to Neutral

    3/5/26 8:27:42 AM ET
    $META
    Computer Software: Programming Data Processing
    Technology

    Meta Platforms upgraded by Erste Group

    Erste Group upgraded Meta Platforms from Hold to Buy

    3/5/26 8:23:30 AM ET
    $META
    Computer Software: Programming Data Processing
    Technology

    $ACON
    $AIRE
    $ATNI
    $AZN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NYSE Content Update: Two-time Olympic Champions Have a Bell Moment on the Trading Floor

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 13, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastornardi delivers the pre-market update on March 13thU.S. stock market indices are on track for weekly losses as ICE Brent Crude oil, the international benchmark, rises amid the conflict in Iran.On NYSE Live, Bitcoin Standard Treasury Company Co-Founder and CIO Sean Bill will share how his company is working to maximize bitcoin's value.Rugby will meet the NYSE as th

    3/13/26 8:55:00 AM ET
    $CL
    $ICE
    $NOW
    Package Goods/Cosmetics
    Consumer Discretionary
    Investment Bankers/Brokers/Service
    Finance

    BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

    New results demonstrate early VOXZOGO treatment leads to durable and sustained improvements in skeletal growth-related health outcomes, including proportionality, arm span and body mass index, building on over 10,000 patient-years of data  VOXZOGO is the only approved treatment for children with achondroplasia starting at birth and has the most extensive published clinical evidence, including in measures beyond growth, among all achondroplasia treatmentsSAN RAFAEL, Calif., March 12, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced positive new data from studies of VOXZOGO® (vosoritide) in children with achondroplasia in ongoing clinical trials and real-world st

    3/12/26 9:05:00 AM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    reAlpha (NASDAQ: AIRE) Reports Fourth Quarter and Full Year 2025 Results; Record Full-Year Revenue of $4.5 Million, Up 376% Year Over Year

    DUBLIN, Ohio, March 12, 2026 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (NASDAQ:AIRE) (the "Company" or "reAlpha"), an AI-powered real estate technology company, today announced financial results for the quarter and full year ended December 31, 2025. Full Year Financial Highlights (All figures are approximate and compared to FY 2024 unless otherwise stated) Revenue increased 376% to $4.5 million, compared to $0.9 million in FY 2024. The increase was driven primarily by increased revenue from mortgage brokerage transactions from reAlpha Mortgage, subscription fees from AiChat's AI conversational technologies, and revenues generated from Prevu's real estate services following its acquisition

    3/12/26 8:35:00 AM ET
    $AIRE
    Real Estate
    Finance

    $ACON
    $AIRE
    $ATNI
    $AZN
    SEC Filings

    View All

    Tyler Technologies Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - TYLER TECHNOLOGIES INC (0000860731) (Filer)

    3/13/26 10:26:46 AM ET
    $TYL
    Computer Software: Prepackaged Software
    Technology

    Barfresh Food Group Inc. filed SEC Form 8-K: Leadership Update

    8-K - BARFRESH FOOD GROUP INC. (0001487197) (Filer)

    3/13/26 9:00:44 AM ET
    $BRFH
    Packaged Foods
    Consumer Staples

    Sleep Number Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Sleep Number Corp (0000827187) (Filer)

    3/12/26 5:19:48 PM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    $ACON
    $AIRE
    $ATNI
    $AZN
    Leadership Updates

    Live Leadership Updates

    View All

    RESAAS Appoints Michael Dziekan as Director of Data Strategy

    VANCOUVER, BC, March 12, 2026 /CNW/ - RESAAS Services Inc. ("RESAAS") (TSXV:RSS) (OTCQB:RSASF), a leading provider of technology solutions for the real estate industry, is pleased to announce the appointment of Michael Dziekan as Director of Data Strategy. Dziekan will lead RESAAS' data strategy initiatives, focused on expanding the Company's data partnerships, enhancing its global real estate data infrastructure, driving new opportunities for data-driven products and services across the RESAAS platform.Dziekan brings extensive global experience in real estate data, analytics, a

    3/12/26 8:30:00 AM ET
    $IBM
    $SNOW
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    AZZ Inc. Announces Corporate Governance and Other Board Succession Changes

    FORT WORTH, Texas, March 5, 2026 /PRNewswire/ -- AZZ Inc. (NYSE:AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced the appointment of Aaron Schapper, age 52, and Charles "Chuck" Treadway, age 60, to serve as new members of AZZ's Board of Directors, effective April 8, 2026 which is AZZ's first Board meeting of fiscal year 2027. Mr. Schapper currently serves as President, Chief Executive Officer and a member of the Board of Directors of Myers Industries Inc., a manufacturer of sustainable plastic and metal products that protec

    3/5/26 6:30:00 AM ET
    $AZZ
    Industrial Specialties
    Industrials

    Graco Inc. Announces Appointment of Sanjiv Gupta as Chief Financial Officer and Treasurer; David M. Lowe to Retire After Three Decades of Service

    Graco Inc. (NYSE:GGG) announced today that it has appointed Sanjiv Gupta as Chief Financial Officer and Treasurer, effective April 15, 2026. Gupta will succeed David M. Lowe in the role, who recently informed the company of his intention to retire after a more than thirty-year career with Graco. Gupta joins Graco from General Motors Company (NYSE:GM), where he has spent more than twenty years in various finance and operating roles of increasing leadership responsibility, most recently as Vice President & Chief Financial Officer, GM International. Having also served as Executive Director, Corporate Financial Planning and Analysis, and President and Managing Director, GM India, among other

    3/2/26 5:15:00 PM ET
    $GGG
    $GM
    Fluid Controls
    Industrials
    Auto Manufacturing

    $ACON
    $AIRE
    $ATNI
    $AZN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Technical Officer Guyer Charles Greg sold $996,744 worth of shares (16,486 units at $60.46), decreasing direct ownership by 17% to 79,953 units (SEC Form 4)

    4 - BIOMARIN PHARMACEUTICAL INC (0001048477) (Issuer)

    3/12/26 7:55:45 PM ET
    $BMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by President, RayzeBio Org. Hickey Benjamin

    4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)

    3/12/26 4:24:46 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by EVP, Chief Strategy Officer Shibutani Hiroshi Chris

    4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)

    3/12/26 4:23:48 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $AIRE
    $ATNI
    $AZN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    September 24, 2024 - FDA Roundup: September 24, 2024

    For Immediate Release: September 24, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA held a ribbon-cutting ceremony to highlight the completion of the 64,000 square foot expansion and renovation of the National Forensic Chemistry Center (NFCC)  located in Cincinnati, Ohio.  The goal of this revitalization effort was to impro

    9/24/24 4:08:17 PM ET
    $RS
    Metal Fabrications
    Industrials

    June 14, 2024 - FDA Roundup: June 14, 2024

    For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The proposal would exempt Grade “A” cottage cheese that appears on the Interstate Milk Shippers List from the requirements of the r

    6/14/24 3:54:45 PM ET
    $MMSI
    $BMY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ACON
    $AIRE
    $ATNI
    $AZN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Leibowitz Arthur S bought $13,405 worth of shares (5,000 units at $2.68), increasing direct ownership by 2% to 291,014 units (SEC Form 4)

    4 - Organogenesis Holdings Inc. (0001661181) (Issuer)

    3/11/26 9:45:54 PM ET
    $ORGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Driscoll Michael Joseph bought $26,688 worth of shares (10,000 units at $2.67), increasing direct ownership by 5% to 225,707 units (SEC Form 4)

    4 - Organogenesis Holdings Inc. (0001661181) (Issuer)

    3/11/26 5:45:41 PM ET
    $ORGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP AND CFO Vasquez Alison Gaut bought $49,983 worth of shares (4,218 units at $11.85), increasing direct ownership by 8% to 57,607 units (SEC Form 4)

    4 - Orion Group Holdings Inc (0001402829) (Issuer)

    3/9/26 5:52:35 PM ET
    $ORN
    Military/Government/Technical
    Industrials

    $ACON
    $AIRE
    $ATNI
    $AZN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/9/24 5:37:15 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/4/24 4:15:14 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/3/24 4:34:49 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACON
    $AIRE
    $ATNI
    $AZN
    Financials

    Live finance-specific insights

    View All

    reAlpha (NASDAQ: AIRE) Reports Fourth Quarter and Full Year 2025 Results; Record Full-Year Revenue of $4.5 Million, Up 376% Year Over Year

    DUBLIN, Ohio, March 12, 2026 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (NASDAQ:AIRE) (the "Company" or "reAlpha"), an AI-powered real estate technology company, today announced financial results for the quarter and full year ended December 31, 2025. Full Year Financial Highlights (All figures are approximate and compared to FY 2024 unless otherwise stated) Revenue increased 376% to $4.5 million, compared to $0.9 million in FY 2024. The increase was driven primarily by increased revenue from mortgage brokerage transactions from reAlpha Mortgage, subscription fees from AiChat's AI conversational technologies, and revenues generated from Prevu's real estate services following its acquisition

    3/12/26 8:35:00 AM ET
    $AIRE
    Real Estate
    Finance

    Sleep Number Announces Fourth Quarter and Full Year 2025 Results

    Reports FY2025 Net Sales of $1.4 Billion, Exceeding Adjusted EBITDA Guidance Realized $185 Million of Annualized Cost Savings Launches New Products as the Next Phase of Turnaround Strategy to Return to Profitable Growth Sleep Number Corporation (NASDAQ:SNBR) today reported results for fourth quarter and the year ended January 3, 2026. Linda Findley, President and CEO, commented, "Sleep Number exceeded 2025 guidance provided on our last earnings call. We are still in full turnaround mode and made significant progress against our new product and marketing strategies while continuing to reduce costs. For the full year 2025, pro-forma adjusted EBITDA margin was approximately 9% and anti

    3/12/26 7:00:00 AM ET
    $SNBR
    Home Furnishings
    Consumer Discretionary

    Ultralife Corporation Reports Fourth Quarter Results

    NEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Fourth Quarter: Sales of $48.5 million compared to $43.9 million for the 2024 fourth quarterGross profit of $12.1 million, or 24.9% of revenue, compared to $10.6 million, or 24.2% of revenue, for the 2024 fourth quarterOperating (loss) income of ($10.6) million, which includes a ($12.2) million intangible asset impairment charge and ($1.2) million of one-time costs, compared to $1.5 million for the 2024 fourth quarterGAAP EPS of ($0.45), which includes ($0.57) for the intangible asset impairment charge net

    3/10/26 7:00:00 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous